Biotech news
Refine search
Americas
American biotech 3Scan is combining robotics with machine learning and automation to offer microscopy services for the 3D analysis of cells, tissues, and organs. LSIPR met general counsel Nada Rastad to hear about some of the patenting challenges. 24 September 2018
Americas
ERS Genomics and the Broad Institute of MIT and Harvard signed CRISPR licensing deals with Thermo Fisher Scientific on Tuesday, shortly before ERS expanded a separate agreement with Oxford Genetics. 20 September 2018
Americas
Several recent cases from the US Court of Appeals for the Federal Circuit offer guidance on navigating the §101 legal framework with respect to CRISPR patent claims, as Pat Carson and Mira Atanassova Mulvaney of Kirkland & Ellis report. 19 September 2018
Americas
Gene-editing company CRISPR Therapeutics has partnered with regenerative medicine-focused ViaCyte to focus on diabetes treatments. 19 September 2018
Pharma
Researchers from three London universities and the Francis Crick Institute have joined together to form a hub for cancer biotherapeutics research and treatment, made possible by a £14 million investment from charity Cancer Research UK. 19 September 2018
Americas
Allergan has revealed plans to buy Bonti, a biotechnology company focused on medical aesthetics, for $195 million. 18 September 2018
Pharma
Personalised healthcare is a rapidly developing field, not just because of medical advancements, but also because the criteria necessary to secure second medical use patents has similarly evolved over the years, an industry webinar heard. 13 September 2018
Americas
Boston-based Nutter McClennen & Fish has added a team of IP professionals: three partners, two of counsels, one associate, and one technical specialist. 13 September 2018
Americas
Lino Almazan-Monroy and Mariana Gonzalez-Vargas of Becerril, Coca & Becerril discuss how inventors seeking patents for polymorphs in Mexico can give themselves the best chance of success. 11 September 2018
Biotech
Biotech company Shire yesterday revealed plans to acquire a Switzerland-based plasma collection company. 7 September 2018


